(Q33953740)

30 July 2017

title

A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia (English)

1 reference

30 July 2017

1 reference

S Tsutsui

1

1 reference

30 July 2017

Zolipidem Study Group

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2001

1 reference

Journal of International Medical Research

30 July 2017

published in

1 reference

30 July 2017

volume

29

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

163-177

1 reference

The perspective of management of sleep disorders in Japan

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

The safety and tolerability of zolpidem--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

The Pharmacology and Mechanism of Action of Zolpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

New insights into the mechanism of action of hypnotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Benzodiazepines, memory and mood: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

The amnesic action of benzodiazepines in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Polysomnographic effects of hypnotic drugs. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000102900303

10.1177/147323000102900303

21 January 2018

Identifiers

DOI

1 reference

release_2k4cnkz6vjcdzizphhzhzxa7xi

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2k4cnkz6vjcdzizphhzhzxa7xi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference